ClearPoint Neuro (CLPT) Revenue Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 42.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.93% |
| Dec 31, 2025 | 33.96% |
| Sep 30, 2025 | 9.10% |
| Jun 30, 2025 | 17.27% |
| Mar 31, 2025 | 11.07% |
| Dec 31, 2024 | 14.11% |
| Sep 30, 2024 | 40.96% |
| Jun 30, 2024 | 32.07% |
| Mar 31, 2024 | 40.60% |
| Dec 31, 2023 | 31.62% |
| Sep 30, 2023 | 11.97% |
| Jun 30, 2023 | 14.42% |
| Mar 31, 2023 | 7.99% |
| Dec 31, 2022 | 20.83% |
| Sep 30, 2022 | 12.51% |
| Jun 30, 2022 | 52.36% |
| Mar 31, 2022 | 24.84% |
| Dec 31, 2021 | 15.23% |
| Sep 30, 2021 | 29.98% |
| Jun 30, 2021 | 37.73% |
| Mar 31, 2021 | 29.33% |
| Dec 31, 2020 | 149.50% |
| Sep 30, 2020 | 20.21% |
| Jun 30, 2020 | -4.93% |
| Mar 31, 2020 | 26.03% |
| Dec 31, 2019 | -429.73% |
| Sep 30, 2019 | 62.00% |
| Jun 30, 2019 | 58.32% |
| Mar 31, 2019 | 52.31% |
| Sep 30, 2016 | 33.66% |
| Jun 30, 2016 | 3,546.45% |
| Mar 31, 2016 | 39.85% |
| Sep 30, 2015 | 105.55% |
| Jun 30, 2015 | -97.47% |
| Mar 31, 2015 | 18.76% |
| Dec 31, 2014 | 101.39% |
| Sep 30, 2014 | 1,973.24% |
| Jun 30, 2014 | 132.13% |
| Mar 31, 2014 | 434.30% |
| Dec 31, 2013 | -157.54% |
| Sep 30, 2013 | -97.49% |
| Jun 30, 2013 | 249.27% |
| Mar 31, 2013 | 42.11% |
| Dec 31, 2012 | 930.07% |
| Sep 30, 2012 | -2.00% |
| Jun 30, 2012 | 95.38% |
| Mar 31, 2012 | -86.04% |